OrbiMed Advisors »

Pepgen shares owned by OrbiMed Advisors

Quarter-by-quarter ownership of Pepgen (PEPG) shares owned by OrbiMed Advisors from 13F filings

Historical chart of OrbiMed Advisors investment in Pepgen

Tip: Access up to 7 years of quarterly data

All positions including Pepgen held by OrbiMed Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pepgen by OrbiMed Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $6.8M 797k 8.55

More positions owned by OrbiMed Advisors

Edgewise Therapeutics (EWTX)
Sinovac Biotech SHS (SVA)
Eli Lilly & Co. (LLY)
Boston Scientific Corporation (BSX)
Intuitive Surgical Com New (ISRG)
Enliven Therapeutics (ELVN)
Biogen Idec (BIIB)
Merck & Co (MRK)
Tenet Healthcare Corp Com New (THC)
Sarepta Therapeutics (SRPT)
Stryker Corporation (SYK)
Silverback Therapeutics (SPRY)
Argenx Se Sponsored Adr (ARGX)
UnitedHealth (UNH)
Q32 Bio (QTTB)

View all positions for OrbiMed Advisors

Top funds holding Pepgen

RA Capital Management
Suvretta Capital Management
Viking Global Investors
Perceptive Advisors
BlackRock
BlackRock
Vanguard Group
Laurion Capital Management
OrbiMed Advisors
Frazier Life Sciences Management
Henderson Group
Octagon Capital Advisors
Geode Capital Management
State Street Corporation
Opaleye Management

View all funds holding Pepgen